Trevena
TRVN
#10609
Rank
S$0.01 M
Marketcap
S$0.01555
Share price
0.00%
Change (1 day)
-99.29%
Change (1 year)

Trevena (TRVN) - Cash on Hand

Cash on Hand as of September 2024 : S$17.44 Million

According to Trevena's latest financial reports the company has S$17.44 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Trevena - Cash on Hand chart (from 2012 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$43.55 M-15.23%
2022-12-31S$51.37 M-43.22%
2021-12-31S$90.47 M-37.49%
2020-12-31S$0.14 B199.83%
2019-12-31S$48.27 M-42.53%
2018-12-31S$83.99 M-4.99%
2017-12-31S$88.4 M-44.77%
2016-12-31S$0.16 B-34.45%
2015-12-31S$0.24 B72.88%
2014-12-31S$0.14 B193.67%
2013-12-31S$48.1 M483.7%
2012-12-31S$8.24 M-62.7%
2011-12-31S$22.09 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
S$12.23 B 70,060.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
S$1.24 B 7,050.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
S$49.11 M 181.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$23.60 B 135,199.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
S$12.15 M-30.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA